Report on a WHO Consultation on the characterisation of BCG strains, Imperial College, London 15–16 December 2003 (original) (raw)
WHO Informal Consultation on standardization and evaluation of BCG vaccines Geneva, Switzerland 22–23 September 2009
Ivana Knezevic
Vaccine, 2010
View PDFchevron_right
International Collaborative Study to evaluate and establish WHO Reference Reagents for BCG vaccine of three different substrains
Jason Hockley
View PDFchevron_right
The establishment of sub-strain specific WHO Reference Reagents for BCG vaccine
Jason Hockley
Vaccine, 2014
View PDFchevron_right
The BCG World Atlas: A Database of Global BCG Vaccination Policies and Practices
Aman Verma
PLOS Medicine, 2011
View PDFchevron_right
International collaborative study to evaluate and establish the 1st WHO reference reagent of BCG vaccine of moreau-RJ sub-strain
Jason Hockley
2012
View PDFchevron_right
Report of an international collaborative study to establish the suitability of using modified ATP assay for viable count of BCG vaccine
Ivana Knezevic
Vaccine, 2008
View PDFchevron_right
BCG Vaccination as a Prevention Strategy, Threats and Benefits
fariba shirvani
Archives of Pediatric Infectious Diseases, 2016
View PDFchevron_right
Availability and use of Standards in vaccine development
Anna Särnefält
npj Vaccines
View PDFchevron_right
Development of New Tuberculosis Vaccines: A Global Perspective on Regulatory Issues
Julie Milstien, Rosemary Tiernan
PLoS Medicine, 2007
View PDFchevron_right
The influence of BCG vaccine strain on the immune response against tuberculosis: a randomised trial
Nicole Ritz
View PDFchevron_right
The second Geneva Consensus: Recommendations for novel live TB vaccines
Roland Dobbelaer, G. Thiry
Vaccine, 2010
View PDFchevron_right
Data collection on the impact of the BCG vaccine on the rate of tuberculosis cases worldwide (Atena Editora)
Atena Editora
Data collection on the impact of the BCG vaccine on the rate of tuberculosis cases worldwide (Atena Editora), 2022
View PDFchevron_right
Applying Experiences from Trials of Bacille Calmette-Guérin Vaccine
Mary E Wilson
Clinical Infectious Diseases, 2000
View PDFchevron_right
Protection by BCG Vaccine Against Tuberculosis: A Systematic Review of Randomized Controlled Trials
Laura Rodrigues
Clinical Infectious Diseases, 2014
View PDFchevron_right
Tuberculosis vaccine development: Current status and future directions
Kaushik Bharati
Editorial, 2019
View PDFchevron_right
Report of an international collaborative study to evaluate the suitability of multiplex PCR as an identity assay for different sub-strains of BCG vaccine
mei-hwei ho
Vaccine, 2010
View PDFchevron_right
Tuberculosis vaccine: A journey from BCG to present
Gobardhan Das
Life Sciences, 2020
View PDFchevron_right
New use of BCG for recombinant vaccines
Raul Barletta
Nature, 1991
View PDFchevron_right
Vaccination strategies to prevent tuberculosis in the new millennium: from BCG to new vaccine candidates
Jose Ignacio Gregorio Santos
International Journal of Infectious Diseases, 2006
View PDFchevron_right
Comparative Genomics of BCG Vaccines by Whole-Genome DNA Microarray
Marcel Behr
Science, 1999
View PDFchevron_right
Influence of BCG vaccine strain on the immune response and protection against tuberculosis
Nicole Ritz, Roy Robins-browne
FEMS microbiology reviews, 2008
View PDFchevron_right
Tuberculosis II: the failure of the BCG vaccine
Roland Maes
Medical Hypotheses, 1999
View PDFchevron_right
Thirty years of recombinant BCG: new trends for a centenary vaccine
Luana Moraes
Expert Review of Vaccines, 2021
View PDFchevron_right
An update on vaccines for tuberculosis – there is more to it than just waning of BCG efficacy with time
Kris Huygen
Expert Opinion on Biological Therapy, 2012
View PDFchevron_right
After 100 Years of BCG Immunization against Tuberculosis, What Is New and Still Outstanding for This Vaccine?
Mario Alberto Flores-Valdez
Vaccines, 2021
View PDFchevron_right
Causes of variation in BCG vaccine efficacy: Examining evidence from the BCG REVAC cluster randomized trial to explore the masking and the blocking hypotheses
Laura Rodrigues
Vaccine, 2014
View PDFchevron_right
The Efficacy of the BCG Vaccine against Newly Emerging Clinical Strains of Mycobacterium tuberculosis
Crystal Shanley
PLOS ONE, 2015
View PDFchevron_right
A century of BCG: Impact on tuberculosis control and beyond
Asma Ahmed
Immunological Reviews, 2021
View PDFchevron_right